Urine soluble tumor necrosis factor receptor for diagnosis of deep venous thrombosis

Invention: Urine soluble tumor necrosis factor receptor for diagnosis of deep venous thrombosis

Year	Description
1998	Invention patented by Syde A. Taheri on August 17th, 1998. Abstract: A method for predicting the presence of deep venous thrombosis in a patient comprises measuring the concentration of soluble tumor necrosis factor receptor-1 (p55) in the patient's urine and comparing the measured concentration to an established baseline concentration. A concentration in the patient's urine greater than the established baseline concentration is predictive of the presence of deep venous thrombosis.
Source: selected by the editor from original sources.